Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%
Showing
1-20 of 212
Advances In Cancer Immunotherapy

Advances In Cancer Immunotherapy

Advances in Cancer Immunotherapy answers key questions such as: What is the immuno-oncology market forecast to be worth by 2020? Which checkpoint inhibitors are approved in the USA? Which immunotherapies are expected to reach blockbuster status ...
$995.00
Read More
Advances in the Biosimilars and Injectable Generics Market 2016

Advances in the Biosimilars and Injectable Generics Market 2016

The injectable generics sector has been through a sustained period of consolidation over the last few years as the leading companies have increased their presence through acquisition. With this in mind, the increased level of ...
$995.00
Read More
Asia Pharmaceuticals & Healthcare Report

Asia Pharmaceuticals & Healthcare Report

BMI View : Asia is a key growth opportunity for pharmaceutical firms. The sector's growth is supported by a solid economic foundation, projected to outperform with an average real GDP growth of 5% as compared to 3% ...
$1,295.00
Read More
Brexit Implications: UK And Beyond

Brexit Implications: UK And Beyond

Update: In the wake of the UK's momentous decision to leave the European Union, we have published a special report (UK Votes Leave: What Next?). The report is a comprehensive 162-page report on the potential ...
$580.00
Read More
Costa Rica Pharmaceuticals & Healthcare Report

Costa Rica Pharmaceuticals & Healthcare Report

BMI View: The approved loan from the World Bank will help improve the institutional management and organisation of healthcare delivery in Costa Rica's public healthcare sector, as well as enhance the financial sustainability of ...
$1,295.00
Read More
El Salvador Pharmaceuticals & Healthcare Report

El Salvador Pharmaceuticals & Healthcare Report

BMI View: El Salvador's slowly improving regulatory regime will continue to open up the local drug market to international players. The local government's commitment to healthcare will further improve the national healthcare system ...
$1,295.00
Read More
Emerging Markets: The Next Generation

Emerging Markets: The Next Generation

The special report draws upon BMI’s expertise to provide maximum integration of our macroeconomic, commodity and industry analysis. The views are integrated, forward looking and independent. In addition to the established major EMs ...
$1,106.00
Read More
Europe Pharmaceuticals & Healthcare Report

Europe Pharmaceuticals & Healthcare Report

BMI View: Europe will remain the most attractive region for multinational pharmaceutical firms over the coming years. The Western European region is defined by highly developed markets with significant demand for both patented and generic ...
$1,295.00
Read More
Global Pharmaceuticals & Healthcare Report

Global Pharmaceuticals & Healthcare Report

BMI View: Pharmaceutical companies will face an increasing number of external risks to their operations. Many of these new challenges emanate from the global financial crisis of 2007/ 08. In an era of fiscal pressures, governments are ...
$1,295.00
Read More
Guatemala Pharmaceuticals & Healthcare Report

Guatemala Pharmaceuticals & Healthcare Report

BMI View: Due to its small market size and low per capita pharmaceutical spending, the Guatemalan pharmaceutical market will continue to attract limited multinational drugmaker investment in 2016. Generic drugmakers in Latin America will continue to ...
$1,295.00
Read More
Honduras Pharmaceuticals & Healthcare Report

Honduras Pharmaceuticals & Healthcare Report

BMI View: Inequity and low coverage will continue to characterise the healthcare sector in Honduras. The local government will continue to support the primary healthcare network and promote the decentralisation of the healthcare sector. In 2016, ...
$1,295.00
Read More
Latin America Pharmaceuticals & Healthcare Report

Latin America Pharmaceuticals & Healthcare Report

BMI View : Latin America's pharmaceutical market will continue to be viewed as an important means to expand multinational drugmakers emerging market presence , despite the deteriorating political and economic outlook in the short term. The ...
$1,295.00
Read More
Middle East And North Africa Pharmaceuticals & Healthcare Report

Middle East And North Africa Pharmaceuticals & Healthcare Report

BMI View : Expanding healthcare access through the implementation of health insurance scheme s and greater private sector support will provide long-term commercial opportunities for multinational pharmaceutical companies. However, governments are expected to be increasingly strict ...
$1,295.00
Read More
Nicaragua Pharmaceuticals & Healthcare Report

Nicaragua Pharmaceuticals & Healthcare Report

BMI View: Nicaragua will continue to be the least attractive pharmaceutical market in Central America due to l imited healthcare funding, low per capita pharmaceutical expenditure, a substandard regulation system and socio-cultural preference for traditional ...
$1,295.00
Read More
Panama Pharmaceuticals & Healthcare Report

Panama Pharmaceuticals & Healthcare Report

BMI View: The local government's increasing investment in the public healthcare system will significantly improve the population 's access to medicines and provide revenue-generating opportunities for pharmaceutical companies. The business-friendly environment and Colon Free ...
$1,295.00
Read More
Pharmaceuticals & Healthcare Q116 Round-Up

Pharmaceuticals & Healthcare Q116 Round-Up

The Pharmaceuticals & Healthcare Q116 Round-Up features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments. BMI's Pharmaceuticals & ...
$580.00
Read More
Pharmaceuticals & Healthcare Q216 Round-Up

Pharmaceuticals & Healthcare Q216 Round-Up

The Pharmaceuticals & Healthcare Q216 Round-Up features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments. BMI's Pharmaceuticals & ...
$580.00
Read More
Pharmaceuticals & Healthcare Q415 Round-Up

Pharmaceuticals & Healthcare Q415 Round-Up

The global pharmaceutical market is set to post a compound annual growth rate of 2.6% over the next five years. Combined sales of prescription drugs and over-the-counter medicines increased from USD1,043bn in 2013 to USD1,080bn ...
$580.00
Read More
Sub-Saharan Africa Pharmaceuticals & Healthcare Report

Sub-Saharan Africa Pharmaceuticals & Healthcare Report

The Sub-Saharan Africa Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments. BMI's ...
$1,295.00
Read More
The Year Ahead: Global Industries Outlook 2016 - Mid-Year Update

The Year Ahead: Global Industries Outlook 2016 - Mid-Year Update

In this first edition of the bi-annual special report series The Year Ahead: Global Industries Outlook we assess the progress of the themes we identified across 12 core industries in December 2015 for the year ahead, and ...
$580.00
Read More
Showing
1-20 of 212